Completed the acquisition of the Medical Cannabis by Shopper’s Drug Mart business.
Launch of Avicanna’s new medical cannabis care platform MyMedi.ca.
TORONTO, Aug. 01, 2023 (GLOBE NEWSWIRE) — Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products is pleased to announce it has closed of the previously announced acquisition of the Medical Cannabis by Shopper’s Business (“Business”) from Shoppers Drug Mart® and pleased to announce the launch of an all-new medical cannabis care platform, MyMedi.ca.
Today, MyMedi.ca, a medical cannabis care platform, has officially launched nationwide in Canada. The platform’s features include:
- Medical Cannabis Marketplace: A diverse medical cannabis marketplace featuring approximately 200 unique products supplied by a network of 35 brands from various leading Canadian licensed producers.
- Pharmacist-Led Patient Care Services: Pharmacist-led fully bilingual (English and French) patient care service programs including pharmacovigilance, compassionate pricing, and insurance adjudication in compliance with standards established by private and public payers.
- Patient Education: Patient education programs and informational resources, including harm reduction strategies and risk mitigation.
- Education for Healthcare Professionals: Medical education, training, and resources available to health care practitioners, hospitals, clinics, and institutions, along with potential collaboration opportunities, through the Company’s Medical Affairs department
“We are pleased to have closed the acquisition of the Business from Shoppers Drug Mart® and recognize this as a transformational milestone in the life of our Company. We would like to express our gratitude to the incredible network of collaborators who came together to ensure a smooth transition for the patients and deliver this medical platform that is adhering to required standards of patient privacy and care. We are motivated to meet the needs of our new patients through MyMedi.ca and welcome the thousands of patients that have transitioned over from the Medical Cannabis by Shoppers platform,” stated Aras Azadian, CEO of Avicanna.
About Avicanna Inc.
Avicanna is a commercial-stage international biopharmaceutical company focused on the advancement and commercialization of evidence-based cannabinoid-based products for the global medical and pharmaceutical market segments. Avicanna has an established scientific platform including R&D and clinical development that has led to the commercialization of more than thirty products across various market segments:
Sean Hocking
Source link
